Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Int J Exp Pathol
2022 Jun 01;1033:112-120. doi: 10.1111/iep.12444.
Show Gene links
Show Anatomy links
Pre-analytical processing protocol of breast biopsies affects multigene panel results.
Lima VR
,
da Costa Aguiar Alves B
,
Fonseca FLA
,
Zveibil DK
,
Del Giglio A
.
???displayArticle.abstract???
The creation of multigene panels for prognostic and predictive purposes allows a more accurate indication of adjuvant chemotherapy for patients with breast cancer. In a previous study, we reproduced a multigene panel of 21 genes based on the commercial Oncotype-DX method. We submitted 183 embedded specimens obtained from breast surgery on patients with locoregional disease (stages I to III) between 2005 and 2010 performed at the Hospitals of the Medical School of the ABC Foundation. When we analysed the correlations between the score of the multigene panel and the progression-free interval (PFI) in all patients, we did not find a statistically significant association. However, when we selected only the 71 samples that had amplification of at least eight non-housekeeping genes, we observed that those with scores above the 75th percentile had a significantly lower PFI (p = .0054). Samples processed with nonbuffered formaldehyde were associated with a worse quality of extracted RNA (p = .004) and a significantly higher multigene panel score (p = .021). We conclude that variations in the pre-analytical processing of specimens destined for multigene panel amplification can significantly affect the results, with a potential impact on clinical management.
Abdueva,
Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays.
2010, Pubmed
Abdueva,
Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays.
2010,
Pubmed
Bass,
A review of preanalytical factors affecting molecular, protein, and morphological analysis of formalin-fixed, paraffin-embedded (FFPE) tissue: how well do you know your FFPE specimen?
2014,
Pubmed
Beaulieu,
Analytical performance of a qRT-PCR assay to detect guanylyl cyclase C in FFPE lymph nodes of patients with colon cancer.
2010,
Pubmed
Bohmann,
RNA extraction from archival formalin-fixed paraffin-embedded tissue: a comparison of manual, semiautomated, and fully automated purification methods.
2009,
Pubmed
Casasanta,
Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.
2020,
Pubmed
Coates,
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
2015,
Pubmed
Cronin,
Analytical validation of the Oncotype DX genomic diagnostic test for recurrence prognosis and therapeutic response prediction in node-negative, estrogen receptor-positive breast cancer.
2007,
Pubmed
Engel,
Effects of preanalytical variables on the detection of proteins by immunohistochemistry in formalin-fixed, paraffin-embedded tissue.
2011,
Pubmed
Giuliano,
Breast Cancer-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
2017,
Pubmed
Godfrey,
Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction.
2000,
Pubmed
Guerrero,
Effects of formalin fixation and prolonged block storage on detection of hepatitis C virus RNA in liver tissue.
1997,
Pubmed
Krop,
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.
2017,
Pubmed
Kuniyoshi,
Gene profiling and circulating tumor cells as biomarker to prognostic of patients with locoregional breast cancer.
2015,
Pubmed
,
Echinobase
Kwa,
Clinical utility of gene-expression signatures in early stage breast cancer.
2017,
Pubmed
Markopoulos,
Multigene assays in early breast cancer: Insights from recent phase 3 studies.
2020,
Pubmed
Paik,
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
2004,
Pubmed
Senkus,
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
2015,
Pubmed
Wang,
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.
NULL,
Pubmed
van de Vijver,
A gene-expression signature as a predictor of survival in breast cancer.
2002,
Pubmed